NM_201596.3:c.1357C>T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_201596.3(CACNB2):c.1357C>T(p.Leu453Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000522 in 1,614,012 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_201596.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNB2 | ENST00000324631.13 | c.1357C>T | p.Leu453Phe | missense_variant | Exon 13 of 14 | 1 | NM_201596.3 | ENSP00000320025.8 | ||
CACNB2 | ENST00000377329.10 | c.1195C>T | p.Leu399Phe | missense_variant | Exon 12 of 13 | 1 | NM_201590.3 | ENSP00000366546.4 |
Frequencies
GnomAD3 genomes AF: 0.000256 AC: 39AN: 152142Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000207 AC: 52AN: 251480Hom.: 0 AF XY: 0.000191 AC XY: 26AN XY: 135914
GnomAD4 exome AF: 0.000550 AC: 804AN: 1461870Hom.: 0 Cov.: 32 AF XY: 0.000523 AC XY: 380AN XY: 727236
GnomAD4 genome AF: 0.000256 AC: 39AN: 152142Hom.: 0 Cov.: 31 AF XY: 0.000188 AC XY: 14AN XY: 74310
ClinVar
Submissions by phenotype
Brugada syndrome 4 Uncertain:2
- -
This sequence change replaces leucine, which is neutral and non-polar, with phenylalanine, which is neutral and non-polar, at codon 399 of the CACNB2 protein (p.Leu399Phe). This variant is present in population databases (rs145638628, gnomAD 0.04%), and has an allele count higher than expected for a pathogenic variant. This missense change has been observed in individual(s) with Brugada syndrome (PMID: 20817017, 22090166, 27711072). ClinVar contains an entry for this variant (Variation ID: 402474). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on CACNB2 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
not specified Uncertain:1
Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Reported in 2 probands and in ESP. Possibly in cis with variant above (similar ExAC frequencies) -
not provided Uncertain:1
BP5, PP3 -
Hypertrophic cardiomyopathy Uncertain:1
- -
Cardiovascular phenotype Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at